Axoft shows data from Fleuron probes in 12 patients, including consciousness decoding
Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .
Consciousness-state decoding has so far been shown as a proof of concept in one patient, so these data cannot yet be used to assess critical care patients from cortical recordings.
Axoft (Cambridge, Massachusetts) announced clinical results for its ultra-soft Fleuron depth probes on November 19. In five patients at The Panama Clinic, the probe was implanted acutely into the cortex with classification of anesthetic state. In the first four, wakefulness and sleep states were recorded. This enabled a proof of concept, in the fifth patient, of real-time consciousness decoding without prior training (zero-shot). The data were presented at the Neurocritical Care Society congress on October 20–23 in Seattle. In seven more patients at Mass General Brigham and The Panama Clinic, the probe was placed during planned surgeries to remove a tumor or hematoma. Up to 85% of channels produced recordings of individual neurons with sufficient single-unit spike SNR. The company cites 2.9 million emergency department visits in the US each year due to traumatic brain injuries. It also cites data that 43% of neurocritical care patients are misassessed for their state of consciousness.
Sources 2